Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZIOPHARM Oncology

0.8657
0.0000
Volume:- -
Turnover:1.91M
Market Cap:185.81M
PE:-2.06
High:0.8657
Open:0.8657
Low:0.8657
Close:0.8657
Loading ...

Ziopharm Oncology Provides Leadership and Corporate Updates; Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire
·
26 Feb 2021

BRIEF-Ziopharm Oncology Appoints Timothy Cunningham As Co's Interim Chief Financial Officer

Reuters
·
24 Feb 2021

Ziopharm Oncology to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast on February 25, 2021

GlobeNewswire
·
17 Feb 2021

Analyzing ZIOPHARM Oncology's Unusual Options Activity

Benzinga
·
08 Feb 2021

BRIEF-ZIOPHARM Oncology Increased Size Of Co's Board From Eight To Nine Directors

Reuters
·
05 Feb 2021

Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors

GlobeNewswire
·
05 Feb 2021

BRIEF-ZIOPHARM Oncology Announces Election Of James Huang As Chairman Of The Board

Reuters
·
14 Jan 2021

Ziopharm Oncology Announces Election of James Huang as Chairman of the Board of Directors

GlobeNewswire
·
14 Jan 2021

Ziopharm to Participate in Upcoming January Conferences

GlobeNewswire
·
24 Dec 2020

Companies Like ZIOPHARM Oncology (NASDAQ:ZIOP) Are In A Position To Invest In Growth

Simply Wall St.
·
23 Dec 2020

The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes

Benzinga
·
22 Dec 2020

BRIEF-Ziopharm Oncology Announces Clearance Of Taiwan’S First Ind Of Non-Viral Car-T For The Treatment Of Relapsed Cd19+ Leukemias And Lymphomas

Reuters
·
22 Dec 2020

Ziopharm Oncology Announces Clearance of Taiwan’s First IND of Non-viral CAR-T for the Treatment of Relapsed CD19+ Leukemias and Lymphomas

GlobeNewswire
·
22 Dec 2020

BRIEF-Watermill Asset Management Receives Requisite Number Of Written Consents To Add All 3 Of Its Director Candidates To Ziopharm Oncology's Board

Reuters
·
17 Dec 2020

WaterMill Asset Management Issues Statement Regarding Consent Solicitation at Ziopharm Oncology

Business Wire
·
17 Dec 2020

Are Options Traders Betting on a Big Move in Ziopharm (ZIOP) Stock?

Zacks
·
17 Dec 2020

BRIEF-Spero Therapeutics Appoints Sath Shukla CFO

Reuters
·
17 Dec 2020

ZIOPHARM Oncology - Issued Statement In Connection With Consent Initiated By Watermill Asset Management, Robert Postma And Others

T-Reuters
·
17 Dec 2020

Ziopharm Comments on Consent Solicitation Results

GlobeNewswire
·
17 Dec 2020

The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding

Benzinga
·
15 Dec 2020